Security National Bank of Sioux City Iowa IA Acquires 2,939 Shares of iShares Biotechnology ETF $IBB

Security National Bank of Sioux City Iowa IA increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 31.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,187 shares of the financial services provider’s stock after acquiring an additional 2,939 shares during the period. Security National Bank of Sioux City Iowa IA’s holdings in iShares Biotechnology ETF were worth $2,318,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Bank of America Corp DE lifted its stake in shares of iShares Biotechnology ETF by 10.8% in the 1st quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock valued at $1,225,767,000 after purchasing an additional 707,343 shares during the last quarter. BNP Paribas Financial Markets increased its position in shares of iShares Biotechnology ETF by 11.4% during the 4th quarter. BNP Paribas Financial Markets now owns 2,133,461 shares of the financial services provider’s stock valued at $360,064,000 after purchasing an additional 218,066 shares during the last quarter. LPL Financial LLC increased its position in shares of iShares Biotechnology ETF by 145.9% during the 4th quarter. LPL Financial LLC now owns 992,799 shares of the financial services provider’s stock valued at $167,555,000 after purchasing an additional 589,033 shares during the last quarter. Royal Bank of Canada raised its holdings in iShares Biotechnology ETF by 1.0% during the 1st quarter. Royal Bank of Canada now owns 737,128 shares of the financial services provider’s stock valued at $124,464,000 after buying an additional 7,434 shares during the period. Finally, Barclays PLC raised its holdings in iShares Biotechnology ETF by 61.5% during the 4th quarter. Barclays PLC now owns 671,941 shares of the financial services provider’s stock valued at $113,403,000 after buying an additional 255,750 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 1.2%

IBB traded down $2.51 during trading on Friday, reaching $204.56. The company had a trading volume of 1,355,060 shares, compared to its average volume of 1,639,238. The business has a 50 day simple moving average of $200.00 and a 200-day simple moving average of $182.22. iShares Biotechnology ETF has a 52 week low of $138.79 and a 52 week high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th will be paid a $0.0112 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $0.04 annualized dividend and a dividend yield of 0.0%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.